ADT	androgen deprivation therapy
AF-2	activation function 2
AR	androgen receptor
BC	breast cancer
BPH	benign prostatic hyperplasia
CAFs	cancer-associated fibroblasts
CRPC	castration-resistant prostate cancer
CTCs	circulating tumor cells
17β-diol	5α-androstane-3β
DPN	2,3-bis(4-Hydroxyphenyl)-propionitrile
EGF	epidermal growth factor
EGF-R	epidermal growth factor recpetor
EMT	epithelial-mesenchymal transition
ER	estrogen receptor
ERR	estrogen related receptor
FGF	fibroblast growth factor
GFR	Growth factor receptors
GSK3β	Glycogen synthase kinase- 3β
HES	hairy and enhancer of split
HEY	HES 1 related
HGF	hepatocyte-derived growth factor
HIF	hypoxia-induced factor
IGF-1	insulin-like growth factor 1
IGF-1R	insulin-like growth factor 1 receptor
IHC	immunohistochemistry
LBD	ligand binding domain
Lnc RNA	long non-coding RNA
MAPK	mitogen-activated protein kinase
MET	mesenchymal-epithelial transition
NEAT1	nuclear enriched abundant transcript 1
NF-κB	nuclear factor kappa-light-chain-enhancer of activated B cells
NICD	notch intracellular domain
eNOS	endothelial nitric oxide synthase
NOTCH1	Neurogenic locus notch homolog protein 1
PDGF	platelet-derived growth factor
PD-1	programmed cell death 1
PC	prostate cancer
PHD2	propyl hydroxylase domain 2
PI-3K	Phosphoinositide 3- kinase
PPT	4,4′,4″-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol
RUNX2	regulator Runt-related transcription factor 2
SERM	selective estrogen receptor modulator
sFRP	secreted frizzled-related proteins
SMAD	small mother against decapentaplegic
SNAI	Snail Family Transcriptional Repressor 2
SOX4	sex determining region Y-box
SRs	steroid receptors
TERT	telomerase Reverse Transcriptase
TGF-β	transforming growth factor β
TGF-βR	transforming growth factor β receptor
TWIST1	Twist-related protein 1
VEGF-A	vascular endothelial growth factor A
Wnt	Wingless-INT
ZEB	Zinc finger E-box-binding homeobox